Core Scientific’s (CORZ) Buy Rating Reaffirmed at BTIG Research

Core Scientific (NASDAQ:CORZ)‘s stock had its “buy” rating restated by equities researchers at BTIG Research in a research note issued on Thursday, Benzinga reports. They currently have a $38.00 price target on the stock. BTIG Research’s target price would indicate a potential upside of 201.44% from the company’s current price.

A number of other research analysts have also recently issued reports on CORZ. Citigroup reaffirmed a “market outperform” rating on shares of Core Scientific in a report on Wednesday. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $39.00 price target on shares of Core Scientific in a report on Wednesday. Keefe, Bruyette & Woods upgraded Core Scientific from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $25.00 to $28.00 in a research report on Thursday, July 30th. Wells Fargo & Company started coverage on Core Scientific in a report on Thursday, September 17th. They issued an “overweight” rating and a $28.00 price target for the company. Finally, UBS Group restated a “market outperform” rating on shares of Core Scientific in a report on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, eighteen have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $31.36.

Core Scientific Stock Performance

Shares of CORZ opened at $12.61 on Thursday. Core Scientific has a 1 year low of $12.31 and a 1 year high of $30.46. The stock has a market capitalization of $4.05 billion, a P/E ratio of -2.83 and a beta of 5.49. The company’s fifty day moving average is $17.58 and its two-hundred day moving average is $21.05.

Core Scientific (NASDAQ:CORZ) last posted its quarterly earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($3.26). The company had revenue of $164.20 million for the quarter, compared to analysts’ expectations of $144.83 million. Sell-side analysts predict that Core Scientific will post -1.36 EPS for the current year.

Insider Buying and Selling

In other Core Scientific news, insider Todd DuChene sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $19.97, for a total transaction of $199,700.00. Following the completion of the sale, the insider directly owned 1,969,101 shares in the company, valued at $39,322,946.97. The trade was a 0.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last 90 days, insiders have purchased 19,000 shares of company stock valued at $342,290 and have sold 100,000 shares valued at $1,881,300. Insiders own 1.70% of the company’s stock.

Institutional Trading of Core Scientific

A number of hedge funds have recently made changes to their positions in the company. Bank of America Corp DE grew its stake in shares of Core Scientific by 412.5% during the first quarter. Bank of America Corp DE now owns 4,806,363 shares of the company’s stock valued at $71,903,000 after acquiring an additional 3,868,535 shares in the last quarter. California State Teachers Retirement System raised its position in shares of Core Scientific by 22.1% during the 1st quarter. California State Teachers Retirement System now owns 288,936 shares of the company’s stock valued at $4,322,000 after acquiring an additional 52,260 shares in the last quarter. Man Group plc acquired a new position in Core Scientific in the second quarter worth $1,986,000. Wellington Management Group LLP boosted its holdings in Core Scientific by 45.0% in the second quarter. Wellington Management Group LLP now owns 1,123,721 shares of the company’s stock worth $28,756,000 after purchasing an additional 348,645 shares during the period. Finally, Union Square Park Capital Management LLC bought a new stake in Core Scientific during the first quarter valued at $1,496,000.

Core Scientific News Summary

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analyst targets imply substantial upside. Canaccord Genuity reaffirmed a “Buy” rating with a $36 price target, while BTIG Research maintained its “Buy” rating and set a $38 target. Cantor Fitzgerald also reaffirmed its “Overweight” rating with a $39 target. These targets reflect analysts’ confidence in Core Scientific’s data-center and artificial-intelligence infrastructure growth prospects. Canaccord Genuity analyst rating
• Positive Sentiment: Needham maintained a $35 price target. The firm reiterated its bullish outlook despite credit-related concerns involving CoreWeave, Core Scientific’s tenant and key AI infrastructure customer. Needham reiterates Core Scientific target
• Neutral Sentiment: Third-quarter results are scheduled for November 5. Core Scientific will release fiscal third-quarter 2026 results before market open and host a conference call at 8:30 a.m. Eastern time. The event gives investors a near-term catalyst to assess revenue growth, profitability, data-center expansion and customer concentration. Core Scientific earnings release announcement
• Negative Sentiment: An insider sold $151,200 of stock. Director Todd Duchene sold 10,000 shares at an average price of $15.12, reducing his direct ownership by 0.85%. Although he still owns more than 1.15 million shares, the transaction may add modest selling pressure or raise caution among investors. Core Scientific insider sale
• Negative Sentiment: Credit concerns surrounding CoreWeave could weigh on sentiment. Because CoreWeave is an important tenant, questions about its financial strength could increase concerns about customer concentration, contract execution and the pace of Core Scientific’s AI infrastructure expansion.

Core Scientific Company Profile

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.